Takeda Pharma Company Profile

Aggregated data from the web about Takeda Pharma

Company Name	Takeda Pharma
Website	https://www.takeda.com
Snippet	Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.
Type	Public KK
Owner	Nippon Life (2.24%),[4]BNY Mellon(5.39%)[5]JPMorgan Chase(3.50%)[6]State Street Corporation(1.50%)
Founded	1781
Founder	Chobei Takeda I
Revenue	¥1,770,531 million (FY 2018)[* 1]
Website	takeda.com
Formerly	Chobei Takeda & Co., Ltd. (1925-1943)Takeda Pharmaceutical Industries, Ltd. (English name only 1943-1961)Takeda Chemical Industries, Ltd. (English name only 1961-2004)[2]
Industry	Pharmaceuticals
Traded as	TYO: 4502, NAG: 4502, FSE: 4502, NYSE: TAK, Nikkei 225 component (TYO), TOPIX Core30 component (TYO)
Key people	Yasuchika Hasegawa(Chairman of the Board)Christophe Weber[3](President & CEO)
Net income	¥186,886 million (FY 2012)[* 1]
Native name	武田薬品工業株式会社
Headquarters	Nihonbashi, Chuo, Tokyo, Japan (global headquarters)[citation needed]
Total assets	¥4,106,463 billion (FY 2018)[* 1]
Total equity	¥1,997,424 billion (FY 2018)[* 1]
Romanized name	Takeda Yakuhin Kōgyō kabushiki gaisha
Operating income	¥241,789 million (FY 2018)[* 1]
Number of employees	49,578 (2019)

Takeda Pharma is part of the Japan company list

Takeda Pharma is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.